Paul Beastall

Board Member

Paul is the nominated Director for Innovate UK on the Board of Medicines Discovery Catapult and was appointed in 2022.  He is an engineer who has spent his career working at the interface between technical innovation and successful business, working with organisations from multinational corporations to venture-funded start-ups.

Prior to moving to build a portfolio career, Paul was a member of the Executive team at Cambridge Consultants, an outsourced R&D and technology strategy consultancy, part of Capgemini Group. Prior to that, he held a leadership role in PA Consulting’s Technology Practice.

He is currently Chair of Evonetix, a scale-up developing new instruments to allow the benchtop synthesis of custom DNA directly in researchers’ own laboratories, and Chair of HutanBio, a start-up that is looking to revolutionise the world of transportation through highly robust and innovate algal biofuels that will be grown in the tropical regions.

Paul is a Chartered Engineer and a Fellow of the Institution of Engineering and Technology. He has a Master of Engineering from the University of York.